Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 361

1.

Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.

Figueroa DB, Tillotson J, Li M, Piwowar-Manning E, Hendrix CW, Holtz TH, Bokoch K, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant RM, Bumpus NN.

PLoS One. 2018 Apr 11;13(4):e0195764. doi: 10.1371/journal.pone.0195764. eCollection 2018.

2.

Feasibility and acceptability of conducting HIV vaccine trials in adolescents in South Africa: Going beyond willingness to participate towards implementation.

Wallace M, Middelkoop K, Smith P, Pike C, Bennie T, Chandia J, Churchyard G, Gray G, Latka MH, Mathebula M, Nchabeleng M, Roux S, Slack C, Strode A, Bekker LG.

S Afr Med J. 2018 Mar 28;108(4):291-298. doi: 10.7196/SAMJ.2017.v108i4.12909.

3.

Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa.

Powers KA, Price MA, Karita E, Kamali A, Kilembe W, Allen S, Hunter E, Bekker LG, Lakhi S, Inambao M, Anzala O, Latka MH, Fast PE, Gilmour J, Sanders EJ.

PLoS One. 2018 Apr 3;13(4):e0192785. doi: 10.1371/journal.pone.0192785. eCollection 2018.

4.

'Scared of going to the clinic': Contextualising healthcare access for men who have sex with men, female sex workers and people who use drugs in two South African cities.

Duby Z, Nkosi B, Scheibe A, Brown B, Bekker LG.

South Afr J HIV Med. 2018 Jan 19;19(1):701. doi: 10.4102/sajhivmed.v19i1.701. eCollection 2018.

5.

Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis.

Maljaars LP, Gill K, Smith PJ, Gray GE, Dietrich JJ, Gomez GB, Bekker LG.

South Afr J HIV Med. 2017 Sep 21;18(1):712. doi: 10.4102/sajhivmed.v18i1.712. eCollection 2017.

6.

Attitude shifts and knowledge gains: Evaluating men who have sex with men sensitisation training for healthcare workers in the Western Cape, South Africa.

Scheibe AP, Duby Z, Brown B, Sanders EJ, Bekker LG.

South Afr J HIV Med. 2017 Mar 31;18(1):673. doi: 10.4102/sajhivmed.v18i1.673. eCollection 2017.

7.

Adolescent lives matter: preventing HIV in adolescents.

Pettifor A, Stoner M, Pike C, Bekker LG.

Curr Opin HIV AIDS. 2018 May;13(3):265-273. doi: 10.1097/COH.0000000000000453.

PMID:
29528850
8.

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G 3rd, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V.

PLoS Med. 2018 Mar 1;15(3):e1002514. doi: 10.1371/journal.pmed.1002514. eCollection 2018 Mar.

9.

A systematic review of contraceptive continuation among women living with HIV.

Todd CS, Anderman TC, Long S, Myer L, Bekker LG, Petro GA, Jones HE.

Contraception. 2018 Feb 9. pii: S0010-7824(18)30053-2. doi: 10.1016/j.contraception.2018.02.002. [Epub ahead of print]

PMID:
29432719
10.

A Conditional Economic Incentive Fails to Improve Linkage to Care and Antiretroviral Therapy Initiation Among HIV-Positive Adults in Cape Town, South Africa.

Maughan-Brown B, Smith P, Kuo C, Harrison A, Lurie MN, Bekker LG, Galárraga O.

AIDS Patient Care STDS. 2018 Feb;32(2):70-78. doi: 10.1089/apc.2017.0238.

PMID:
29432045
11.

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC.

AIDS. 2018 Mar 27;32(6):809-818. doi: 10.1097/QAD.0000000000001766.

PMID:
29424774
12.

Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.

Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, Bekker LG.

PLoS One. 2018 Feb 8;13(2):e0191251. doi: 10.1371/journal.pone.0191251. eCollection 2018.

13.

Metabolic Effects of Pre-Exposure Prophylaxis with Co-Formulated Tenofovir Disoproxal Fumarate and Emtricitabine.

Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM.

Clin Infect Dis. 2018 Feb 3. doi: 10.1093/cid/ciy083. [Epub ahead of print]

PMID:
29415175
14.

Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP.

Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, van der Straten A.

AIDS Behav. 2018 Feb 5. doi: 10.1007/s10461-018-2044-2. [Epub ahead of print]

PMID:
29404757
15.

Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.

Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM.

J Clin Virol. 2018 Feb - Mar;99-100:67-70. doi: 10.1016/j.jcv.2018.01.003. Epub 2018 Jan 11.

PMID:
29346085
16.

High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.

Mbulawa ZZA, van Schalkwyk C, Hu NC, Meiring TL, Barnabas S, Dabee S, Jaspan H, Kriek JM, Jaumdally SZ, Muller E, Bekker LG, Lewis DA, Dietrich J, Gray G, Passmore JS, Williamson AL.

PLoS One. 2018 Jan 2;13(1):e0190166. doi: 10.1371/journal.pone.0190166. eCollection 2018.

17.

Comparing four service delivery models for adolescent girls and young women through the 'Girl Power' study: protocol for a multisite quasi-experimental cohort study.

Rosenberg NE, Pettifor AE, Myers L, Phanga T, Marcus R, Bhushan NL, Madlingozi N, Vansia D, Masters A, Maseko B, Mtwisha L, Kachigamba A, Tang J, Hosseinipour MC, Bekker LG.

BMJ Open. 2017 Dec 14;7(12):e018480. doi: 10.1136/bmjopen-2017-018480.

18.

The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review.

Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, Bekker LG, Triant VA.

BMC Public Health. 2017 Dec 15;17(1):954. doi: 10.1186/s12889-017-4940-1. Review.

19.

Association of Adolescent- and Caregiver-Reported Antiretroviral Therapy Adherence with HIV Viral Load Among Perinatally-infected South African Adolescents.

Brittain K, Asafu-Agyei NA, Hoare J, Bekker LG, Rabie H, Nuttall J, Roux P, Stein DJ, Zar HJ, Myer L.

AIDS Behav. 2018 Mar;22(3):909-917. doi: 10.1007/s10461-017-2004-2.

PMID:
29224045
20.

Childbearing intentions among sexually active HIV-infected and HIV-uninfected female adolescents in South Africa.

Adler DH, Abar B, Bennie T, Sadeghi R, Bekker LG.

J AIDS HIV Res. 2017 Jul;9(7):159-163. doi: 10.5897/JAHR2017.0432. Epub 2017 Jul 31.

21.

Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.

Barnabas SL, Dabee S, Passmore JS, Jaspan HB, Lewis DA, Jaumdally SZ, Gamieldien H, Masson L, Muller E, Maseko VD, Mkhize N, Mbulawa Z, Williamson AL, Gray CM, Hope TJ, Chiodi F, Dietrich J, Gray G, Bekker LG; Women’s Initiative in Sexual Health (WISH) study team.

Int J STD AIDS. 2018 May;29(6):531-539. doi: 10.1177/0956462417740487. Epub 2017 Dec 4.

PMID:
29198180
22.

The end of HIV: Still a very long way to go, but progress continues.

Deeks SG, Lewin SR, Bekker LG.

PLoS Med. 2017 Nov 30;14(11):e1002466. doi: 10.1371/journal.pmed.1002466. eCollection 2017 Nov.

23.

The case for viral load testing in adolescents in resource-limited settings.

Marcus R, Ferrand RA, Kranzer K, Bekker LG.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25002. Review.

PMID:
29171180
24.

Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.

Katz IT, Kaplan R, Fitzmaurice G, Leone D, Bangsberg DR, Bekker LG, Orrell C.

PLoS Med. 2017 Nov 14;14(11):e1002434. doi: 10.1371/journal.pmed.1002434. eCollection 2017 Nov.

25.

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Carballo-Diéguez A, Giguere R, Dolezal C, Leu CS, Balán IC, Brown W 3rd, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD; MTN-017 Protocol Team.

AIDS Behav. 2017 Dec;21(12):3336-3345. doi: 10.1007/s10461-017-1969-1.

PMID:
29119473
26.

Comparing Provider and Client Preferences for HIV Prevention Services in South Africa among Men Who Have Sex with Men.

Shaver J, Sullivan P, Siegler A, de Voux A, Phaswana-Mafuya N, Bekker LG, Baral SD, Wirtz AL, Beyrer C, Brown B, Stephenson R.

J Int Assoc Provid AIDS Care. 2017 Nov/Dec;16(6):562-571. doi: 10.1177/2325957417736611. Epub 2017 Nov 6.

PMID:
29108450
27.

Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.

Lennard K, Dabee S, Barnabas SL, Havyarimana E, Blakney A, Jaumdally SZ, Botha G, Mkhize NN, Bekker LG, Lewis DA, Gray G, Mulder N, Passmore JS, Jaspan HB.

Infect Immun. 2017 Dec 19;86(1). pii: e00410-17. doi: 10.1128/IAI.00410-17. Print 2018 Jan.

PMID:
29038128
28.

Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.

Sanders EJ, Price MA, Karita E, Kamali A, Kilembe W, Bekker LG, Lakhi S, Inambao M, Anzala O, Fast PE, Gilmour J, Powers KA.

AIDS. 2017 Nov 28;31(18):2541-2546. doi: 10.1097/QAD.0000000000001659.

29.

Predictors of HIV, HIV Risk Perception, and HIV Worry Among Adolescent Girls and Young Women in Lilongwe, Malawi.

Price JT, Rosenberg NE, Vansia D, Phanga T, Bhushan NL, Maseko B, Brar SK, Hosseinipour MC, Tang JH, Bekker LG, Pettifor A.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):53-63. doi: 10.1097/QAI.0000000000001567.

PMID:
28991885
30.

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.

Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, Marzinke MA, Hendrix CW, Anderson PL, Elharrar V, Stirratt M, Rooney JF, Piwowar-Manning E, Eshleman SH, McKinstry L, Li M, Dye BJ, Grant RM; HPTN 067 (ADAPT) study team.

Lancet HIV. 2018 Feb;5(2):e68-e78. doi: 10.1016/S2352-3018(17)30156-X. Epub 2017 Oct 3.

PMID:
28986029
31.

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Karim SA, Karim QA, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.

PLoS Pathog. 2017 Sep 25;13(9):e1006641. doi: 10.1371/journal.ppat.1006641. eCollection 2017 Sep.

32.

Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.

Walensky RP, Borre ED, Bekker LG, Hyle EP, Gonsalves GS, Wood R, Eholié SP, Weinstein MC, Anglaret X, Freedberg KA, Paltiel AD.

Ann Intern Med. 2017 Nov 7;167(9):618-629. doi: 10.7326/M17-1358. Epub 2017 Aug 29.

PMID:
28847013
33.

Stumbling Blocks at the Clinic: Experiences of Seeking HIV Treatment and Care in South Africa.

Maughan-Brown B, Kuo C, Galárraga O, Smith P, Lurie MN, Bekker LG, Harrison A.

AIDS Behav. 2018 Mar;22(3):765-773. doi: 10.1007/s10461-017-1877-4.

34.

Closing the NIH Fogarty Center threatens US and global health.

Karim SSA, Karim QA, Abimiku A, Bekker LG, Bukusi EA, Deschamps MMH, Derbew M, Garcia PJ, Gray G, Kamya MR, Swaminathan S, Wu Z.

Lancet. 2017 Jul 29;390(10093):451. doi: 10.1016/S0140-6736(17)31912-8. Epub 2017 Jul 27. No abstract available.

PMID:
28792403
35.

Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment.

Maughan-Brown B, Smith P, Kuo C, Harrison A, Lurie MN, Bekker LG, Galárraga O.

AIDS Behav. 2018 Mar;22(3):691-700. doi: 10.1007/s10461-017-1834-2.

36.

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.

Carballo-Diéguez A, Balán IC, Brown W 3rd, Giguere R, Dolezal C, Leu CS, Marzinke MA, Hendrix CW, Piper JM, Richardson BA, Grossman C, Johnson S, Gomez K, Horn S, Kunjara Na Ayudhya RP, Patterson K, Jacobson C, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla C, Lama J, McGowan I, Cranston RD.

PLoS One. 2017 Jul 27;12(7):e0181607. doi: 10.1371/journal.pone.0181607. eCollection 2017.

37.

The International AIDS Society-Lancet Commission on the future of the HIV response and global health.

Beyrer C, Das P, Horton R, Ryan O, Bekker LG.

Lancet. 2017 Jul 22;390(10092):344-345. doi: 10.1016/S0140-6736(17)31874-3. No abstract available.

PMID:
28745592
38.

We still need to beat HIV.

Dabis F, Bekker LG.

Science. 2017 Jul 20. pii: eaao4197. doi: 10.1126/science.aao4197. [Epub ahead of print] No abstract available.

PMID:
28729351
39.

A Potential Animal Model of Maladaptive Palatable Food Consumption Followed by Delayed Discomfort.

Moshe L, Bekker L, Weller A.

Front Neurosci. 2017 Jul 5;11:377. doi: 10.3389/fnins.2017.00377. eCollection 2017.

40.

Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier.

Joseph Davey DL, Bekker LG, Gorbach PM, Coates TJ, Myer L.

AIDS. 2017 Oct 23;31(16):2193-2197. doi: 10.1097/QAD.0000000000001604. No abstract available.

PMID:
28723709
41.

In memoriam: Mark Wainberg, PhD (1945-2017).

Sow PS, Kippax S, Bras M, Mayer KH, Bekker LG, Beyrer C.

J Int AIDS Soc. 2017 Jul 13;20(1):22206. doi: 10.7448/IAS.20.1.22206. No abstract available.

42.

The science of Durban, AIDS 2016.

Beyrer C, Shisana O, Baral SD, Milsana K, Mayer KH, Pozniak A, Walker BD, Mboup S, Sohn AH, Serwadda D, Rees H, Dvoriak S, Warren M, Thiam S, El-Sadr WM, Hospital X, Ryan O, Thomson N, Bekker LG.

J Int AIDS Soc. 2017 Jun 30;20(1):21781. doi: 10.7448/IAS.20.1.21781.

43.

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.

Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, Buchbinder SP, Bekker LG, Schechter M, Grinsztejn B, Grant RM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):177-182. doi: 10.1097/QAI.0000000000001475.

PMID:
28639995
44.

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.

Squires K, Bekker LG, Katlama C, Yazdanpanah Y, Zhou Y, Rodgers AJ, DiNubile MJ, Sklar PA, Leavitt RY, Teppler H.

Open Forum Infect Dis. 2017 Feb 28;4(1):ofw047. doi: 10.1093/ofid/ofw047. eCollection 2017 Winter.

45.

Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM; MTN-020/ASPIRE Study.

AIDS. 2017 May 15;31(8):1159-1167. doi: 10.1097/QAD.0000000000001452.

46.

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.

Truong HM, Mehrotra M, Montoya O, Lama JR, Guanira JV, Casapía M, Veloso VG, Buchbinder SP, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Grant RM.

Sex Transm Dis. 2017 May;44(5):306-309. doi: 10.1097/OLQ.0000000000000601.

PMID:
28407648
47.

Adolescents' experience of a rapid HIV self-testing device in youth-friendly clinic settings in Cape Town South Africa: a cross-sectional community based usability study.

Smith P, Wallace M, Bekker LG.

J Int AIDS Soc. 2016 Dec 23;19(1):21111. doi: 10.7448/IAS.19.1.21111. [Epub ahead of print]

48.

Crossing the Finish Line.

Goosby E, Abrams E, Bekker LG, Mushavi A.

J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S106-S107. doi: 10.1097/QAI.0000000000001315. No abstract available.

PMID:
28399004
49.

Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.

Sivay MV, Li M, Piwowar-Manning E, Zhang Y, Hudelson SE, Marzinke MA, Amico RK, Redd A, Hendrix CW, Anderson PL, Bokoch K, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant R, Eshleman SH; HPTN 067/ADAPT Study Team.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):271-279. doi: 10.1097/QAI.0000000000001374.

PMID:
28328548
50.

Hope for HIV control in southern Africa: The continued quest for a vaccine.

Bekker LG, Gray GE.

PLoS Med. 2017 Feb 28;14(2):e1002241. doi: 10.1371/journal.pmed.1002241. eCollection 2017 Feb.

Supplemental Content

Loading ...
Support Center